OBJECTIVE: Antinuclear antibodies (ANAs) are diagnostic in several autoimmune disorders, yet the failure to achieve B cell tolerance in these diseases is still poorly understood. Although secreted ANAs detected by an indirect immunofluorescence assay are the gold standard for autoreactivity, there has been no convenient assay with which to measure the frequency of circulating B cells that recognize nuclear antigens (ANA+ B cells) in patients. The aim of this study was to generate an assay to easily identify these B cells and to examine its utility in a study of autoreactive B cells in systemic lupus erythematosus (SLE). METHODS: We developed and validated a novel flow cytometry-based assay that identifies ANA+ B cells using biotinylated nuclear extracts, and utilized it to examine B cell tolerance checkpoints in peripheral blood mononuclear cells obtained from SLE patients and healthy controls. RESULTS: We observed progressive selection against ANA+ B cells as they matured from transitional to naive to CD27+IgD- and CD27+IgD+ memory cells in both healthy subjects and SLE patients; however, ANA+ naive B cells in SLE patients were not anergized to the same extent as in healthy individuals. We also showed that anergy induction is restored in SLE patients treated with belimumab, an inhibitor of BAFF. CONCLUSION: This assay will enable studies of large populations to identify potential genetic or environmental factors affecting B cell tolerance checkpoints in healthy subjects and patients with autoimmune disease and permit monitoring of the B cell response to therapeutic interventions.
OBJECTIVE: Antinuclear antibodies (ANAs) are diagnostic in several autoimmune disorders, yet the failure to achieve B cell tolerance in these diseases is still poorly understood. Although secreted ANAs detected by an indirect immunofluorescence assay are the gold standard for autoreactivity, there has been no convenient assay with which to measure the frequency of circulating B cells that recognize nuclear antigens (ANA+ B cells) in patients. The aim of this study was to generate an assay to easily identify these B cells and to examine its utility in a study of autoreactive B cells in systemic lupus erythematosus (SLE). METHODS: We developed and validated a novel flow cytometry-based assay that identifies ANA+ B cells using biotinylated nuclear extracts, and utilized it to examine B cell tolerance checkpoints in peripheral blood mononuclear cells obtained from SLEpatients and healthy controls. RESULTS: We observed progressive selection against ANA+ B cells as they matured from transitional to naive to CD27+IgD- and CD27+IgD+ memory cells in both healthy subjects and SLEpatients; however, ANA+ naive B cells in SLEpatients were not anergized to the same extent as in healthy individuals. We also showed that anergy induction is restored in SLEpatients treated with belimumab, an inhibitor of BAFF. CONCLUSION: This assay will enable studies of large populations to identify potential genetic or environmental factors affecting B cell tolerance checkpoints in healthy subjects and patients with autoimmune disease and permit monitoring of the B cell response to therapeutic interventions.
Authors: Bettina Budeus; Stefanie Schweigle de Reynoso; Martina Przekopowitz; Daniel Hoffmann; Marc Seifert; Ralf Küppers Journal: Proc Natl Acad Sci U S A Date: 2015-08-31 Impact factor: 11.205
Authors: Tâm D Quách; Nataly Manjarrez-Orduño; Diana G Adlowitz; Lin Silver; Hongmei Yang; Chungwen Wei; Eric C B Milner; Iñaki Sanz Journal: J Immunol Date: 2011-03-11 Impact factor: 5.422
Authors: Brun Mietzner; Makoto Tsuiji; Johannes Scheid; Klara Velinzon; Thomas Tiller; Klaus Abraham; Jose B Gonzalez; Virginia Pascual; Dorothee Stichweh; Hedda Wardemann; Michel C Nussenzweig Journal: Proc Natl Acad Sci U S A Date: 2008-07-09 Impact factor: 11.205
Authors: Annett M Jacobi; Karin Reiter; Meggan Mackay; Cynthia Aranow; Falk Hiepe; Andreas Radbruch; Arne Hansen; Gerd-R Burmester; Betty Diamond; Peter E Lipsky; Thomas Dörner Journal: Arthritis Rheum Date: 2008-06
Authors: Guillermo Carvajal Alegria; Pierre Gazeau; Sophie Hillion; Claire I Daïen; Divi Y K Cornec Journal: Clin Rev Allergy Immunol Date: 2017-10 Impact factor: 8.667
Authors: Christopher M Tipton; Jennifer R Hom; Christopher F Fucile; Alexander F Rosenberg; Inaki Sanz Journal: Immunol Rev Date: 2018-07 Impact factor: 12.988
Authors: Mia J Smith; Marynette Rihanek; Brianne M Coleman; Peter A Gottlieb; Virginia D Sarapura; John C Cambier Journal: J Autoimmun Date: 2017-12-09 Impact factor: 7.094
Authors: Mia J Smith; Thomas A Packard; Shannon K O'Neill; Rochelle M Hinman; Marynette Rihanek; Peter A Gottlieb; John C Cambier Journal: J Vis Exp Date: 2017-02-16 Impact factor: 1.355